Fishbein I - Search Results

1

Formulation and in vitro characterization of composite biodegradable magnetic nanoparticles for magnetically guided cell delivery.

Chorny M, Alferiev IS, Fishbein I, Tengood JE, Folchman-Wagner Z, Forbes SP, Levy RJ. Chorny M, et al. Among authors: fishbein i. Pharm Res. 2012 May;29(5):1232-41. doi: 10.1007/s11095-012-0675-y. Epub 2012 Jan 25. Pharm Res. 2012. PMID: 22274555 Free PMC article.

2

Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis.

Fishbein I, Chorny M, Rabinovich L, Banai S, Gati I, Golomb G. Fishbein I, et al. J Control Release. 2000 Mar 1;65(1-2):221-9. doi: 10.1016/s0168-3659(99)00244-8. J Control Release. 2000. PMID: 10699282

3

Drug delivery systems for the treatment of restenosis.

Chorny M, Fishbein I, Golomb G. Chorny M, et al. Among authors: fishbein i. Crit Rev Ther Drug Carrier Syst. 2000;17(3):249-84. Crit Rev Ther Drug Carrier Syst. 2000. PMID: 10868290 Review.

4

Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles.

Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V, Sosnowski S, Slomkowski S, Golomb G. Cohen H, et al. Among authors: fishbein i. Gene Ther. 2000 Nov;7(22):1896-905. doi: 10.1038/sj.gt.3301318. Gene Ther. 2000. PMID: 11127577

5

Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model.

Fishbein I, Chorny M, Banai S, Levitzki A, Danenberg HD, Gao J, Chen X, Moerman E, Gati I, Goldwasser V, Golomb G. Fishbein I, et al. Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1434-9. doi: 10.1161/hq0901.095567. Arterioscler Thromb Vasc Biol. 2001. PMID: 11557668

6

Activated polyurethane modified with latent thiol groups.

Alferiev IS, Fishbein I. Alferiev IS, et al. Among authors: fishbein i. Biomaterials. 2002 Dec;23(24):4753-8. doi: 10.1016/s0142-9612(02)00224-7. Biomaterials. 2002. PMID: 12361613

7

Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics.

Chorny M, Fishbein I, Danenberg HD, Golomb G. Chorny M, et al. Among authors: fishbein i. J Control Release. 2002 Oct 30;83(3):389-400. doi: 10.1016/s0168-3659(02)00211-0. J Control Release. 2002. PMID: 12387947

8

Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods.

Chorny M, Fishbein I, Danenberg HD, Golomb G. Chorny M, et al. Among authors: fishbein i. J Control Release. 2002 Oct 30;83(3):401-14. doi: 10.1016/s0168-3659(02)00210-9. J Control Release. 2002. PMID: 12387948

9

The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies.

Burton DY, Song C, Fishbein I, Hazelwood S, Li Q, DeFelice S, Connolly JM, Perlstein I, Coulter DA, Levy RJ. Burton DY, et al. Among authors: fishbein i. Hum Gene Ther. 2003 Jun 10;14(9):907-22. doi: 10.1089/104303403765701196. Hum Gene Ther. 2003. PMID: 12828861

10

Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.

Banai S, Chorny M, Gertz SD, Fishbein I, Gao J, Perez L, Lazarovichi G, Gazit A, Levitzki A, Golomb G. Banai S, et al. Among authors: fishbein i. Biomaterials. 2005 Feb;26(4):451-61. doi: 10.1016/j.biomaterials.2004.02.040. Biomaterials. 2005. PMID: 15275819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page